Mouchard-Delmas C, Gourdier B, Vistelle R, Wiczewski M
Laboratoire de Pharmacologie, U.F.R. de Pharmacie, Reims, France.
Anticancer Res. 1995 Nov-Dec;15(6B):2593-6.
The effects of the antineoplastic compound, vinorelbine, on the permeability of the blood-brain barrier (BBB) to the complex Evans blue/albumin were studied. Vinorelbine, at a dose range from 5 to 10 mg/kg, was infused (4 ml/kg over 2 min) into the left carotid artery of anesthetised male Sprague-Dawley rats. BBB disruption was evaluated, qualitatively, by the appearance in the infused hemisphere of intravenously administered Evans blue dye (2%). Six groups of 3 rats were studied for preliminary assays to define the dose and delay between infusion and sacrifice. Twenty four rats (12 controls and 12 test rats) were used to define the effect of vinorelbine. These effects of vinorelbine were dose dependent and after 3 hours, 10 mg/kg of vinorelbine caused Evans blue/albumin exudation in gray and white matter. This study shows that the intracarotid infusion of vinorelbine in this rat model system increases BBB permeability only with a high dose. Sufficient concentrations of drug may be obtained in cerebral tissue without significant BBB disruption.
研究了抗肿瘤化合物长春瑞滨对血脑屏障(BBB)对伊文思蓝/白蛋白复合物通透性的影响。将剂量范围为5至10mg/kg的长春瑞滨(2分钟内4ml/kg)注入麻醉的雄性Sprague-Dawley大鼠的左颈动脉。通过静脉注射伊文思蓝染料(2%)后在注入侧半球的出现情况,定性评估血脑屏障破坏情况。对六组每组3只大鼠进行初步试验,以确定注射剂量以及注射与处死之间的延迟时间。使用24只大鼠(12只对照大鼠和12只试验大鼠)来确定长春瑞滨的作用。长春瑞滨的这些作用具有剂量依赖性,3小时后,10mg/kg的长春瑞滨导致灰质和白质中伊文思蓝/白蛋白渗出。该研究表明,在这个大鼠模型系统中,颈内注射长春瑞滨仅在高剂量时会增加血脑屏障通透性。在不显著破坏血脑屏障的情况下,可在脑组织中获得足够浓度的药物。